{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:19:29Z","timestamp":1762917569354,"version":"3.40.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.yebeh.2014.12.006","type":"journal-article","created":{"date-parts":[[2015,1,2]],"date-time":"2015-01-02T15:30:35Z","timestamp":1420212635000},"page":"74-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Folate use in women with epilepsy: Predictors of adherence in a specialized tertiary outclinic"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6904-2562","authenticated-orcid":false,"given":"Valmir","family":"Passarelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nath\u00e1lia Stela Vison\u00e1","family":"de Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora Bartzen","family":"Moraes Angst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meire Argentoni","family":"Baldocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Sheila","family":"Guimar\u00e3es Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2014.12.006_bb0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.0b013e3181a6b312","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.0b013e3181a6b325","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0b013e3181a6b2f8","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0020","first-page":"87","article-title":"Social class, complications, and perinatal deaths in pregnancies of epileptics women: preliminary results of the prospective Helsinki study","volume":"1","author":"Hiilesmaa","year":"1982","journal-title":"Epilepsy Pregnancy Child"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0890-6238(93)90010-5","article-title":"Practices of epilepsy during pregnancy: a survey of Canadian neurologists","volume":"7","author":"Morrison","year":"1993","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0030","first-page":"521","article-title":"Epilepsy and pregnancy: evolution and fetal outcome","volume":"24","author":"Lorenzato","year":"2002","journal-title":"RBGO"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1528-1167.2008.01926.x","article-title":"Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest","volume":"49","author":"Pennell","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0920-1211(92)90011-H","article-title":"An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy","volume":"13","author":"Sander","year":"1992","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0045","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.0013-9580.2004.451101.x","article-title":"EURAP: an international registry of antiepileptic drugs and pregnancy","volume":"45","author":"Tomson","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.yebeh.2003.11.020","article-title":"Oxcarbazepine in pregnancy: clinical experience in Argentina","volume":"5","author":"Meischenguiser","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00003495-198530020-00003","article-title":"Drugs and folate metabolism","volume":"30","author":"Lambie","year":"1985","journal-title":"Drugs"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0060","first-page":"234","article-title":"Australian pregnancy register of women on antiepileptic drugs: 5-year results","volume":"45","author":"Vadja","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0065","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","article-title":"Valproic acid monotherapy in pregnancy and major congenital malformations","volume":"362","author":"Jentink","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0070","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM200104123441504","article-title":"The teratogenicity of anticonvulsant drugs","volume":"344","author":"Holmes","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0140-6736(91)90133-A","article-title":"Prevention of neural tube defects: results of the Medical Research Council Vitamin Study","volume":"338","author":"Medical Research Council (MRC) Vitamin Study Research Group","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0080","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ajmg.1320590428","article-title":"Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring","volume":"59","author":"Shaw","year":"1995","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0085","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/(SICI)1096-9926(199606)53:6<345::AID-TERA5>3.0.CO;2-Z","article-title":"Population-based case control study of folic acid supplementation during pregnancy","volume":"53","author":"Czeizel","year":"1996","journal-title":"Teratology"},{"year":"2012","series-title":"The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care","author":"National Institute for Clinical Excellence (NICE)","key":"10.1016\/j.yebeh.2014.12.006_bb0090"},{"year":"2012","series-title":"Guia Pr\u00e1tico de Condutas: Recomenda\u00e7\u00e3o sobre a Suplementa\u00e7\u00e3o Periconcepcional de \u00c1cido F\u00f3lico na Preven\u00e7\u00e3o de Defeitos de Fechamento do Tubo Neural (anencefalia e outros defeitos do tubo neural)","author":"Federa\u00e7\u00e3o Brasileira das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","key":"10.1016\/j.yebeh.2014.12.006_bb0095"},{"year":"2013","series-title":"Guideline: daily supplementation of iron and folic acid in pregnant women","author":"WHO","key":"10.1016\/j.yebeh.2014.12.006_bb0100"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0105","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S1701-2163(16)32685-8","article-title":"Pre-conceptional vitamin\/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies","volume":"29","author":"Wilson","year":"2007","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-3016.2009.01032.x","article-title":"Maternal use of folic acid supplements during pregnancy and four-year-old neurodevelopment in a population-based birth cohort","volume":"23","author":"Julvez","year":"2009","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10995-007-0230-3","article-title":"The effects of prenatal use of folic acid and other dietary supplements on early child development","volume":"12","author":"Wehby","year":"2008","journal-title":"Matern Child Health J"},{"issue":"3","key":"10.1016\/j.yebeh.2014.12.006_bb0120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6years: a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0125","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/jnnp.2008.156109","article-title":"Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"80","author":"Morrow","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"year":"2012","series-title":"Manual de Orienta\u00e7\u00e3o DATN \u2014 Guia Pr\u00e1tico de Condutas \u2014 Recomenda\u00e7\u00e3o sobre a Suplementa\u00e7\u00e3o Periconcepcional de \u00c1cido F\u00f3lico na Preven\u00e7\u00e3o de Defeitos de Fechamento do Tubo Neural (Anencefalia e outros defeitos abertos do tubo neural)","key":"10.1016\/j.yebeh.2014.12.006_bb0130"},{"year":"2013","series-title":"Recommendation number 02\/2013","key":"10.1016\/j.yebeh.2014.12.006_bb0135"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0140","first-page":"60","article-title":"Pregnancy and epilepsy","volume":"20","author":"Harden","year":"2014","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40264-013-0052-8","article-title":"Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland","volume":"36","author":"Artama","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0150","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0967-5868(03)00158-9","article-title":"The Australian registry of anti-epileptic drugs in pregnancy: experience after 30months","volume":"10","author":"Vajda","year":"2003","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1528-1157.44.s4.2.x","article-title":"Reproductive and metabolic disorders in women with epilepsy","volume":"44","author":"Morrell","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yebeh.2012.03.001","article-title":"Patient knowledge about issues related to pregnancy in epilepsy: a cross-sectional study","volume":"24","author":"Metcalfe","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.12.006_bb0165","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S1059-1311(03)00085-2","article-title":"Understanding the information needs of women with epilepsy at different lifestages: results of the \u2018Ideal World\u2019 survey","volume":"12","author":"Crawford","year":"2003","journal-title":"Seizure"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501400660X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501400660X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T10:53:53Z","timestamp":1537959233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550501400660X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":33,"alternative-id":["S152550501400660X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.12.006","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Folate use in women with epilepsy: Predictors of adherence in a specialized tertiary outclinic","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}